Revolution Medicines (RVMD)
(Delayed Data from NSDQ)
$35.33 USD
-0.26 (-0.73%)
Updated Apr 25, 2024 04:00 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
RVMD 35.33 -0.26(-0.73%)
Will RVMD be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for RVMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RVMD
Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Tops Revenue Estimates
Revolution Medicines, Inc. (RVMD) Reports Q4 Loss, Lags Revenue Estimates
RVMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts See a 27.5% Upside in Revolution Medicines, Inc. (RVMD): Can the Stock Really Move This High?
Revolution Medicines, Inc. (RVMD) Reports Q3 Loss, Lags Revenue Estimates
Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Tops Revenue Estimates
Other News for RVMD
Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Revolution Medicines (RVMD)
Top 10 stocks with upwards and downwards daily percentage change - Piper Sandler
Top 3 Health Care Stocks That May Collapse In Q2
Revolution Medicines price target raised by $2 at Oppenheimer, here's why
Oppenheimer Sticks to Their Buy Rating for Revolution Medicines (RVMD)